TTBB CAS 124750-51-2 Purity >96.0% (HPLC) Irbesartan Intermediate Factory

Short Description:

Name: 5-(4′-Bromomethyl-1,1′-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazole

Synonyms: TTBB

CAS: 124750-51-2

Purity: >96.0% (HPLC)

Appearance: White to Almost White Powder

Intermediate of Irbesartan (CAS: 138402-11-6)

E-Mail: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Ruifu Chemical Supply Irbesartan Intermediates:
Irbesartan CAS 138402-11-6
Cyano-Irbesartan CAS 138401-24-8
Trityl Irbesartan CAS 138402-10-5
TTBB CAS 124750-51-2
Irbesartan Side Chain Hydrochloride CAS 151257-01-1

Chemical Properties:

Chemical Name	5-(4'-Bromomethyl-1,1'-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazole
Synonyms	TTBB; BBTT; 5-[4'-Bromomethyl-(1,1'-Biphenyl)-2-yl]-1-Triphenylmethyltetrazole; N-(Triphenylmethyl)-5-(4'-Bromomethylbiphenyl-2-yl-)tetrazole; Olmesartan Impurity 12; Losartan Bromo N1-Trityl Impurity
CAS Number	124750-51-2
CAT Number	RF-PI1878
Stock Status	In Stock, Production Capacity 150MT/Year
Molecular Formula	C33H25BrN4
Molecular Weight	557.48
Melting Point	152.0~155.0℃
Density	1.28±0.10 g/cm3
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	White to Almost White Powder
Purity / Analysis Method	>96.0% (HPLC)
Loss on Drying	<0.50%
Impurity A	<2.00% (HPLC) 5-(4-Methyl-1,1-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazole
Impurity B	<2.00% 5-(4'.4'-Dibromomethyl-1,1-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazole
Infrared Spectrum	Conforms to Structure
Test Standard	Enterprise Standard
Usage	Intermediate of Irbesartan (CAS: 138402-11-6); Olmesartan Medoxomil Impurity

Package & Storage:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture

Advantages:

FAQ:

Application:

5-(4'-Bromomethyl-1,1'-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazole (TTBB) (CAS: 124750-51-2) is an intermediate of Irbesartan (CAS: 138402-11-6). Irbesartan is used for the treatment of hypertension, as well as diabetic nephropathy with an elevated serum creatinine and proteinuria (>300 mg/day) in patients with type 2 diabetes and hypertension. Irbesartan is also used as a second line agent in the treatment of conges. Irbesartan is an angiotensin II receptor antagonist used mainly for the treatment of hypertension. It was developed by Sanofi Research (now part of Sanofi-Aventis). It is jointly marketed by Sanofi-Aventis and Bristol-Myers Squibb under the trade names Aprovel, Karvea, and Avapro.